|
|
|
|
|
|
|
| Cryosurgery for Prostate Cancer |
|
Cryocare® TCAP™ (Targeted Cryoablation of the Prostate™) is a minimally invasive prostate cancer new treatment that uses ice to destroy prostate cancer. The -40°C temperature is instantly lethal to cancer, resulting in immediate prostate cancer cell death.
Cryocare TCAP is approved by Medicare as a primary treatment for prostate cancer. It's also approved as a treatment of prostate cancer for recurrent prostate cancer after any type of radiation.
Today over 350 published studies help document the clinical value of cryoablation as a prostate cancer treatment option. And recent 10 year data provides evidence of cryoablation's long-term durability. The Cryocare procedure has been performed on thousands of men by hundreds of doctors nationwide.
With Cryocare TCAP, the physician inserts 6-8 slender probes into the prostate gland. Contained within each probe is argon gas cold enough to freeze the entire prostate. A warming catheter protects the urethra from the very cold temperatures. Ultrasound images allow your doctor to guide the probes to the best possible positions for destroying the cancer. Temperature sensors carefully monitor the process and precisely determine when target temperatures have been reached.
Recent studies have shown that for some men Cryocare TCAP prostate cancer treatment may be performed with minimal damage to the nerves necessary for sexual function. Ask your doctor if this is an appropriate option for you.
Cryocare CS is a fully integrated planning, placement and treatment system designed to simplify cryotherapy and allow unlimited flexibility. Cryocare CS is designed to meet specific physician needs through innovative, user-friendly technology that introduces a new generation of cryotherapy.
Why Consider Cryoablation?
- Minimally invasive prostate cancer treatment, not major surgery
- No radiation beams, no permanent radiation seeds, no radiation exposure
- Choice of general or spinal anesthesia
- Outpatient or overnight hospital stay
- Fast return to normal lifestyle
- Low risk of potential side effects (such as incontinence)
- Covered by Medicare and most insurance plans as a treatment for prostate cancer
- Recent published studies have demonstrated good long-term outcomes from doctors performing the Cryocare TCAP prostate cancer treatment.
The preceding information is used with permission from Endocare, Inc.
For more information on this topic, go to: http://www.cryocarepca.org/
|
READ MORE ON THIS SUBJECT IN OUR RESOURCE CENTER
|
USMD Hospital at Arlington •
801 West Interstate 20 •
Arlington, Texas 76017 •
Phone (817) 472-3400
Please read our Notice of Privacy Practices
© USMD Hospital 2007 |
This Web site presents information to educate consumers on various health topics. It is NOT intended to provide instruction on medical diagnosis or treatment.
The information contained on this site is compiled from a variety of sources. It may not be complete or timely. It does not cover all diseases, physical conditions, ailments or treatments. You should NOT rely on this information to determine a diagnosis or course of treatment. The information should NOT be used in place of an individual consultation, examination, visit or call with your physician or other qualified health care provider. You should never disregard the advice of your physician or other qualified health care provider because of any information you read on this site or on any Web sites you visit as a result of using this site. If you have any health care questions, please consult your physician or other qualified health care provider promptly. Always consult your physician or other qualified health care provider before you begin any new treatment, diet or fitness program.
|
|
|
